Postoperative C-Reactive Protein/Albumin Ratio: A New Era in Predicting Mortality After Coronary Artery Bypass Grafting
DOI:
https://doi.org/10.37609/srinmed.44Anahtar Kelimeler:
Coronary artery bypass grafting- postoperative inflammation- C-reactive protein to albumin ratio- mortality prediction- systemic inflammationÖz
Aim: Coronary artery bypass grafting is one of the most commonly performed surgical procedures for patients with advanced coronary artery disease. However, postoperative complications and mortality remain significant concerns. Systemic inflammation and nutritional status are crucial factors influencing surgical outcomes. The prognostic value of biomarkers that simultaneously assess these parameters in the postoperative period remains unclear. The C-reactive protein to albumin ratio has emerged as a novel biomarker reflecting both inflammation and nutritional status.
This study aims to evaluate the role of postoperative C-reactive protein to albumin ratio in predicting early mortality in patients undergoing coronary artery bypass grafting. Specifically, the impact of postoperative inflammatory response and nutritional status on patient outcomes will be analyzed.
Methods: This retrospective observational study included 350 patients who underwent coronary artery bypass grafting. Preoperative and postoperative biochemical markers, including C-reactive protein, albumin, and C-reactive protein to albumin ratio, were analyzed. The primary outcome was 30-day mortality. Logistic regression models were applied to assess the independent association between postoperative C-reactive protein to albumin ratio and mortality, adjusting for potential confounders.
Results: Patients with higher postoperative C-reactive protein to albumin ratio had significantly increased mortality rates (p = 0.0155). While preoperative values did not show a significant association with mortality (p = 0.5178), postoperative levels emerged as a strong predictor. Elevated postoperative urea levels were also independently associated with mortality (p < 0.0001).
Conclusions: Postoperative C-reactive protein to albumin ratio is an independent predictor of early mortality in patients undergoing coronary artery bypass grafting.
İndirmeler
Referanslar
Benjamin EJ, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.
Schmidt AF, et al. Unravelling the difference between men and women in post-CABG survival. Front Cardiovasc Med. 2022;9:768972.
Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications: A review for emergency clinicians. Am J Emerg Med. 2018;36(12):2289-2297.
Gaudino M, et al. Arterial grafts for coronary bypass: a critical review after the publication of ART and RADIAL. Circulation. 2019;140(15):1273-1284.
Suleiman M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47(5):962-968.
Aksoy F, Uysal D, Ibrişim E. Relationship between C-reactive protein/albumin ratio and new-onset atrial fibrillation after coronary artery bypass grafting. Rev Assoc Med Bras. 2020;66(8):1070-1076.
Pilatis ND, et al. The role of BNP and CRP in predicting the development of atrial fibrillation in patients undergoing isolated coronary artery bypass surgery. Int Scholarly Res Notices. 2013;2013:235018.
Liu Y, et al. The prognostic value of C-reactive protein to albumin ratio in patients with sepsis: a systematic review and meta-analysis. Aging Male. 2023;26(1):2261540.
Chen C, et al. Association between preoperative hs-CRP/albumin ratio and postoperative SIRS in elderly patients: a retrospective observational cohort study. J Nutr Health Aging. 2022;26(4):352-359.
Kahraman S, et al. The prognostic value of C-reactive protein to albumin ratio in patients with isolated degenerative aortic valve stenosis undergoing surgical aortic valve replacement. Braz J Cardiovasc Surg. 2019;35(3):299-306.
Berbel-Franco D, et al. The influence of postoperative albumin levels on the outcome of cardiac surgery. J Cardiothorac Surg. 2020;15:1-13.
Fang J, et al. Association of preoperative high C-reactive protein to albumin ratio with adverse outcomes after elective non-cardiac surgery in older patients: a multicenter prospective study. J Inflamm Res. 2024;:9255-9268.
Çağdaş M, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70(4):361-368.
Park JE, et al. The C-reactive protein/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med. 2018;7(10):333.
Ridker PM, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-1565.
Xu, Ruoxin, et al. “Preoperative hypoalbuminemia in patients undergoing cardiac surgery: a meta-analysis.” Surgery Today 53.8 (2023): 861-872.
Llop-Talaveron J, Badia-Tahull MB, Leiva-Badosa E. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition. Clin Nutr. 2018;37(5):1575-1583.
Seoudy H, et al. C-reactive protein to albumin ratio in patients undergoing transcatheter aortic valve replacement. Mayo Clin Proc. 2022;97(5):.
Karabağ Y, et al. Relationship between C‐reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32(7):e22457.
Karas PL, Goh SL, Dhital K. Is low serum albumin associated with postoperative complications in patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2015;21(6):777-786.
Katkat F, et al. C-reactive protein to albumin ratio as a novel inflammatory-based marker for 30-day mortality in patients undergoing transcatheter aortic valve replacement. Braz J Cardiovasc Surg. 2022;37(3):292.
Mohamed SA, ElHawary R. C-Reactive protein/albumin ratio as an independent predictor of mortality in critically ill pediatric patients. J Child Sci. 2020;10(1):e1-e11.
Artac I, et al. Assessment of the relationship between C-reactive protein to albumin ratio and late-term mortality in patients with acute pulmonary embolism. Asian Cardiovasc Thorac Ann. 2023;31(4):332-339.
Oh AR, et al. Preoperative C-reactive protein/albumin ratio and mortality of off-pump coronary artery bypass graft. Front Cardiovasc Med. 2024;11:1354816.
Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: A retrospective analysis. Sci Rep. 2018;8(1):14977.
Xu X, et al. Evaluation of the prognostic role of neutrophil-lymphocyte ratio, C-reactive protein-albumin ratio, and platelet-lymphocyte ratio in patients with the co-presentation of coronary artery disease and COVID-19. Infect Drug Resist. 2024;:885-897.
Kilinc A, et al. Effects of prognostic nutrition index, neutrophil/lymphocyte ratio, and C-reactive protein/albumin ratio on prognosis undergoing open heart surgery. 2025.
Menon V, et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003;42(1):44-52.
Bayrak M. Predictive value of C-reactive protein/albumin ratio in patients with chronic complicated diabetes mellitus. Pak J Med Sci. 2019;35(6):1616.
Çınar T, et al. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53(2):83-90.
İndir
Yayınlanmış
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2025 Scientific Reports in Medicine
Bu çalışma Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License ile lisanslanmıştır.
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allows users to copy, distribute and transmit unmodified article, and make noncommercial use of the article. The CC BY license permits non-commercial re-use of an open access article, as long as the author is properly attributed.
